Netherlands vs Singapore: Estimated antiretroviral therapy coverage among people living with HIV
Netherlands
89.0%
in 2024
Singapore
89.0%
in 2024
Netherlands rank
22nd
Singapore rank
22nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Netherlands
- Singapore
How they compare
Netherlands currently reports 89.0% against 89.0% in Singapore, a difference of 0.0%.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Netherlands ahead.
Netherlands ranks 22nd and Singapore ranks 22nd of 143 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.5% | 20.5% | 33.0% | Netherlands |
| 2010s | 77.1% | 74.8% | 2.3% | Netherlands |
| 2020s | 87.8% | 87.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Netherlands or Singapore?
- Netherlands, at 89.0% against 89.0% in Singapore as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Netherlands and Singapore?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Singapore?
- 25 years are reported by both, from 2000 to 2024.
- How do Netherlands and Singapore rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Netherlands ranks 22nd and Singapore ranks 22nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.